Allen RP, Walters AS, Montplaisir J, et al., authors. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–92. [PubMed]
Winkelman JW, Finn L, Young T, authors. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7:545–52. [PubMed]
Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P, authors. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61–5. [PubMed]
Phillips B, Hening W, Britz P, Mannino D, authors. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest. 2006;129:76–80. [PubMed]
Lee HB, Hening WA, Allen RP, et al., authors. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20:101–5. [PubMed]
Hening WA, Allen RP, Chaudhuri KR, et al., authors. Clinical significance of RLS. Mov Disord. 2007;22 Suppl 18:S395–400. [PubMed]
Rye DB, Trotti LM, authors. Restless legs syndrome and periodic leg movements of sleep. Neurol Clin. 2012;30:1137–66. [PubMed]
American Academy of Sleep Medicine. 2014. http://www.aasmnet.org/aboutaasm.aspx.
Morgenthaler TI, Aronsky AJ, Carden KA, Chervin RD, Thomas SM, Watson NF, authors. Measurement of quality to improve care in sleep medicine. J Clin Sleep Med. 2015;11:279–91.
Benes H, Walters AS, Allen RP, Hening WA, Kohnen R, authors. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22 Suppl 18:S401–8. [PubMed]
Ondo WG, author. Common comorbidities and differential diagnosis of restless legs syndrome. J Clin Psychiatry. 2014;75:e06. [PubMed]
Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG, authors. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88:977–86. [PubMed]
Cuellar NG, Hanlon A, Ratcliffe SJ, authors. The relationship with iron and health outcomes in persons with restless legs syndrome. Clin Nurs Res. 2011;20:144–61. [PubMed]
O'Keeffe ST, Noel J, Lavan JN, authors. Restless legs syndrome in the elderly. Postgrad Med J. 1993;69:701–3. [PubMed Central][PubMed]
Ohayon MM, O'Hara R, Vitiello MV, authors. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16:283–95. [PubMed Central][PubMed]
Curgunlu A, Doventas A, Karadeniz D, et al., authors. Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey. Arch Gerontol Geriatr. 2012;55:73–6. [PubMed]
Sun ER, Chen CA, Ho G, Earley CJ, Allen RP, authors. Iron and the restless legs syndrome. Sleep. 1998;21:371–7. [PubMed]
Frauscher B, Gschliesser V, Brandauer E, et al., authors. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med. 2009;10:611–5. [PubMed]
Hogl B, Oertel WH, Stiasny-Kolster K, et al., authors. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurol. 2010;10:86. [PubMed Central][PubMed]
Trotti LM, Bhadriraju S, Becker LA, authors. Iron for restless legs syndrome. Cochrane Database Syst Rev. 2012;5:CD007834. [PubMed Central][PubMed]
Silber MH, author. Sleep-related movement disorders. Continuum. 2013;19:170–84. [PubMed]
Aurora RN, Kristo DA, Bista SR, et al., authors. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35:1039–62. [PubMed Central][PubMed]
Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM, authors. Ferritin for the clinician. Blood Rev. 2009;23:95–104. [PubMed Central][PubMed]
Weinstock LB, Walters AS, Paueksakon P, authors. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. Sleep Med Rev. 2012;16:341–54. [PubMed]
Silber MH, Richardson JW, authors. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clinic Proc. 2003;78:52–4.
Walters AS, LeBrocq C, Dhar A, et al., authors. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–32. [PubMed]
Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L, authors. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5:237–46. [PubMed]
Garcia-Borreguero D, Kohnen R, Silber MH, et al., authors. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med. 2013;14:675–84. [PubMed]
Garcia-Borreguero D, Larrosa O, de la Llave Y, Granizo JJ, Allen R, authors. Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med. 2004;5:561–5. [PubMed]
Hogl B, Gschliesser V, Poewe W, authors. Assessing treatment outcome in RLS trials and clinical care: CGI-I, PGI, or VAS? Sleep Med. 2013;14:125–6. [PubMed]
Trenkwalder C, Kohnen R, Allen RP, et al., authors. Clinical trials in restless legs syndrome--recommendations of the European RLS Study Group (EURLSSG). Mov Disord. 2007;22 Suppl 18:S495–504. [PubMed]
Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M, authors. Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev. 2011;CD006009. [PubMed]
Godau J, Spinnler N, Wevers AK, Trenkwalder C, Berg D, authors. Poor effect of guideline based treatment of restless legs syndrome in clinical practice. J Neurol Neurosurg Psychiatry. 2010;81:1390–5. [PubMed]
Wilt TJ, MacDonald R, Ouellette J, et al., authors. Treatment for restless legs syndrome. comparative effectiveness review No. 86. AHRQ Publication. 2012;12(13).
Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C, authors. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Sleep Med Rev. 2014;18:153–64. [PubMed]
Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, et al., authors. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol. 2012;19:1385–96. [PubMed]
Trenkwalder C, Benes H, Grote L, et al., authors. Prolonged release oxycodonenaloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12:1141–50. [PubMed]
Atkinson MJ, Sinha A, Hass SL, et al., authors. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12. [PubMed Central][PubMed]
Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
Schnipper JL, Kirwin JL, Cotugno MC, et al., authors. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71. [PubMed]
Agency for Healthcare Research and Quality. Treatment for restless legs syndrome: clinician research summary. AHRQ Publication. 2013;12:EHC147–3.
Bayard S, Langenier MC, Dauvilliers Y, authors. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. Sleep. 2013;36:1501–7. [PubMed Central][PubMed]
Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH, authors. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. 2010;33:81–7. [PubMed Central][PubMed]
Voon V, Potenza MN, Thomsen T, authors. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol. 2007;20:484–92. [PubMed]
Evans AH, Butzkueven H, authors. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord. 2007;22:590–1. [PubMed]
Garcia-Borreguero D, Allen RP, Kohnen R, et al., authors. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8:520–30. [PubMed]
de Oliveira MM, Conti CF, Valbuza JS, de Carvalho LB, do Prado GF, authors. The pharmacological treatment for uremic restless legs syndrome: evidence-based review. Mov Disord. 2010;25:1335–42. [PubMed]
Picchietti DL, Hensley JG, Bainbridge JL, et al., authors. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev. 2014 Nov 4.[Epub ahead of print].
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.